Efficacy in Early AD Patients

Picture4

Buntanetap showed statistically significant efficacy and safety in both carriers and non-carriers of Apolipoprotein E4 (APOE4), a genetic cause of AD.

Format

JPEG

Source

Annovis Bio, Inc.

Downloads